PhoY2 but Not PhoY1 is the PhoU Homologue Involved in Persisters in Mycobacterium Tuberculosis

Overview

Journal J Antimicrob Chemother

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2010 Apr 3

PMID 20360062

Citations 29

Authors

Wanliang Shi

Ying Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: Mycobacterial persistence is thought to be the underlying cause of the current lengthy tuberculosis therapy and latent infection. Despite some recent progress, the mechanisms of bacterial persistence are poorly understood. We have recently identified a new persister gene phoU from Escherichia coli and have shown that the phoU mutant has a defect in persisters. The objective of this study is to evaluate the role of two phoU homologues phoY1 and phoY2 from Mycobacterium tuberculosis in mycobacterial persistence.

Methods: M. tuberculosis phoY1 and phoY2 mutant strains were constructed. The persister-related phenotypes of the phoY1 and phoY2 mutants were assessed in vitro by MIC testing, drug exposure assays and also by survival in the mouse model of tuberculosis infection.

Results: We demonstrated that M. tuberculosis PhoY2 is the equivalent of E. coli PhoU in that inactivation of phoY2 but not phoY1 caused a defect in persistence phenotype as shown by increased susceptibility to rifampicin and pyrazinamide in both MIC testing and drug exposure assays and also reduced persistence in the mouse model.

Conclusions: This study provides further validation that PhoU is involved in persistence not only in E. coli but also in M. tuberculosis and has implications for the development of new drugs targeting persisters for improved treatment.

Citing Articles

Bacterial persisters: molecular mechanisms and therapeutic development.

Niu H, Gu J, Zhang Y Signal Transduct Target Ther. 2024; 9(1):174.

PMID: 39013893 PMC: 11252167. DOI: 10.1038/s41392-024-01866-5.

A Bibliometric Analysis of Research on Bacterial Persisters.

Ju Y, Zhang F, Yu P, Zhang Y, Zhao P, Xu P Biomed Res Int. 2023; 2023:4302914.

PMID: 36644164 PMC: 9839416. DOI: 10.1155/2023/4302914.

Activation of the SigE-SigB signaling pathway by inhibition of the respiratory electron transport chain and its effect on rifampicin resistance in Mycobacterium smegmatis.

Oh Y, Lee H, Jeong J, Kim S, Oh J J Microbiol. 2022; 60(9):935-947.

PMID: 35913593 DOI: 10.1007/s12275-022-2202-0.

Tandem Mass Tag-Based Quantitative Proteomics and Virulence Phenotype of Hemolymph-Treated Bacillus thuringiensis kurstaki Cells Reveal New Insights on Bacterial Pathogenesis in Insects.

Sun Y, Yang L, Rodriguez-Cabrera L, Ding Y, Leng C, Qiao H Microbiol Spectr. 2021; 9(2):e0060421.

PMID: 34704785 PMC: 8549738. DOI: 10.1128/Spectrum.00604-21.

Insights into the molecular determinants involved in persistence and their therapeutic implications.

Joshi H, Kandari D, Bhatnagar R Virulence. 2021; 12(1):2721-2749.

PMID: 34637683 PMC: 8565819. DOI: 10.1080/21505594.2021.1990660.

References

Gandhi N, Moll A, Sturm A, Pawinski R, Govender T, Lalloo U . Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368(9547):1575-80. DOI: 10.1016/S0140-6736(06)69573-1. View

Zhang Y, Garbe T, Young D . Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol. 1993; 8(3):521-4. DOI: 10.1111/j.1365-2958.1993.tb01596.x. View

Balaban N, Merrin J, Chait R, Kowalik L, Leibler S . Bacterial persistence as a phenotypic switch. Science. 2004; 305(5690):1622-5. DOI: 10.1126/science.1099390. View

Lewis K . Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2006; 5(1):48-56. DOI: 10.1038/nrmicro1557. View

Betts J, Lukey P, Robb L, McAdam R, Duncan K . Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002; 43(3):717-31. DOI: 10.1046/j.1365-2958.2002.02779.x. View

Steed P, Wanner B . Use of the rep technique for allele replacement to construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role for the PhoU protein in the phosphate regulon. J Bacteriol. 1993; 175(21):6797-809. PMC: 206803. DOI: 10.1128/jb.175.21.6797-6809.1993. View

Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam R . Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1997; 94(20):10961-6. PMC: 23545. DOI: 10.1073/pnas.94.20.10961. View

Moyed H, Bertrand K . hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983; 155(2):768-75. PMC: 217749. DOI: 10.1128/jb.155.2.768-775.1983. View

Wade M, Zhang Y . Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro. J Antimicrob Chemother. 2006; 58(5):936-41. DOI: 10.1093/jac/dkl358. View

10.

Vazquez-Laslop N, Lee H, Neyfakh A . Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J Bacteriol. 2006; 188(10):3494-7. PMC: 1482871. DOI: 10.1128/JB.188.10.3494-3497.2006. View

11.

. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep. 2006; 55(11):301-5. View

12.

Li Y, Zhang Y . PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Antimicrob Agents Chemother. 2007; 51(6):2092-9. PMC: 1891003. DOI: 10.1128/AAC.00052-07. View

13.

McDermott W . Microbial persistence. Yale J Biol Med. 1958; 30(4):257-91. PMC: 2603844. View

14.

Domka J, Lee J, Bansal T, Wood T . Temporal gene-expression in Escherichia coli K-12 biofilms. Environ Microbiol. 2007; 9(2):332-46. DOI: 10.1111/j.1462-2920.2006.01143.x. View

15.

Lee K, Jung J, Kim K, Bae D, Lim D . Overexpression of outer membrane protein OprT and increase of membrane permeability in phoU mutant of toluene-tolerant bacterium Pseudomonas putida GM730. J Microbiol. 2009; 47(5):557-62. DOI: 10.1007/s12275-009-0105-y. View

16.

Glover W, Yang Y, Zhang Y . Insights into the molecular basis of L-form formation and survival in Escherichia coli. PLoS One. 2009; 4(10):e7316. PMC: 2752164. DOI: 10.1371/journal.pone.0007316. View

17.

Mitchison D . The search for new sterilizing anti-tuberculosis drugs. Front Biosci. 2004; 9:1059-72. DOI: 10.2741/1293. View

18.

Dahl J, Kraus C, Boshoff H, Doan B, Foley K, Avarbock D . The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci U S A. 2003; 100(17):10026-31. PMC: 187750. DOI: 10.1073/pnas.1631248100. View

19.

Orme I . A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis. 1988; 137(3):716-8. DOI: 10.1164/ajrccm/137.3.716. View

20.

Korch S, Henderson T, Hill T . Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol Microbiol. 2003; 50(4):1199-213. DOI: 10.1046/j.1365-2958.2003.03779.x. View